335 related articles for article (PubMed ID: 19091854)
1. CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation.
Holfort SK; Lindegaard J; Isager P; Prause JU; Heegaard S
Br J Ophthalmol; 2009 May; 93(5):641-4. PubMed ID: 19091854
[TBL] [Abstract][Full Text] [Related]
2. MRI for the evaluation of scleral invasion and extrascleral extension of uveal melanomas.
Récsán Z; Karlinger K; Fodor M; Zalatnai A; Papp M; Salacz G
Clin Radiol; 2002 May; 57(5):371-6. PubMed ID: 12014934
[TBL] [Abstract][Full Text] [Related]
3. Optic nerve invasion of uveal melanoma: clinical characteristics and metastatic pattern.
Lindegaard J; Isager P; Prause JU; Heegaard S
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3268-75. PubMed ID: 16877391
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
[TBL] [Abstract][Full Text] [Related]
5. [Retrospective study of uveal melanoma].
Tóth J
Magy Onkol; 2005; 49(1):19-25. PubMed ID: 15902329
[TBL] [Abstract][Full Text] [Related]
6. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
[TBL] [Abstract][Full Text] [Related]
7. Uveal and conjunctival malignant melanoma in Denmark, 1943-97: incidence and validation study.
Isager P; Østerlind A; Engholm G; Heegaard S; Lindegaard J; Overgaard J; Storm HH
Ophthalmic Epidemiol; 2005 Aug; 12(4):223-32. PubMed ID: 16033743
[TBL] [Abstract][Full Text] [Related]
8. [Surgical management of orbital malignant melanoma: our experience and a report of three cases].
Poli T; Mora P; Reichegger V; Ricci R; Corradi D; Gandolfi SA; Sesenna E
Klin Monbl Augenheilkd; 2007 Oct; 224(10):794-8. PubMed ID: 17952825
[TBL] [Abstract][Full Text] [Related]
9. Variates of survival in metastatic uveal melanoma.
Rietschel P; Panageas KS; Hanlon C; Patel A; Abramson DH; Chapman PB
J Clin Oncol; 2005 Nov; 23(31):8076-80. PubMed ID: 16258106
[TBL] [Abstract][Full Text] [Related]
10. Melanoma associated spongiform scleropathy: characterization, biochemical and immunohistochemical studies.
Alyahya GA
Acta Ophthalmol; 2008 Oct; 86 Thesis 3():1-21. PubMed ID: 18826517
[TBL] [Abstract][Full Text] [Related]
11. Optic nerve invasion of uveal melanoma.
Lindegaard J; Isager P; Prause JU; Heegaard S
APMIS; 2007 Jan; 115(1):1-16. PubMed ID: 17223846
[TBL] [Abstract][Full Text] [Related]
12. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
Coupland SE; Campbell I; Damato B
Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathways mediating liver metastasis in patients with uveal melanoma.
Bakalian S; Marshall JC; Logan P; Faingold D; Maloney S; Di Cesare S; Martins C; Fernandes BF; Burnier MN
Clin Cancer Res; 2008 Feb; 14(4):951-6. PubMed ID: 18281525
[TBL] [Abstract][Full Text] [Related]
14. ["Melanoma 92". epidemiological study of uveal melanoma in France].
Vidal JL; Bacin F; Albuisson E; Rozan R; Desjardins L; D'Hermies F; Grange JD; Chauvel P; Caujolle JP; Sahel J
J Fr Ophtalmol; 1995; 18(8-9):520-8. PubMed ID: 7560797
[TBL] [Abstract][Full Text] [Related]
15. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
16. [A survival analysis of patients with malignant uveal melanoma].
Călugăru M; Mera M; Călugăru D
Oftalmologia; 2000; 51(2):45-51. PubMed ID: 11021123
[TBL] [Abstract][Full Text] [Related]
17. Disseminated tumour cells in bone marrow of patients with uveal melanoma.
Eide N; Hoifødt HK; Nesland JM; Faye RS; Qvale GA; Faber RT; Jebsen P; Kvalheim G; Fodstad Ø
Acta Ophthalmol; 2013 Jun; 91(4):343-8. PubMed ID: 22632270
[TBL] [Abstract][Full Text] [Related]
18. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
[TBL] [Abstract][Full Text] [Related]
19. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Vaijayanthi P; Krishnakumar S
Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
[TBL] [Abstract][Full Text] [Related]
20. Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Pushparaj V; Biswas J; Krishnakumar S
Curr Eye Res; 2007 Mar; 32(3):281-90. PubMed ID: 17453948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
